Issue
Alert me when new journal issues are available via or via
Masthead page iii Full-Text PDF (28 KB)
Editorial Board page iv Full-Text PDF (62 KB)
Information for Authors page v Full-Text PDF (30 KB)
Contents pages vii-viii Full-Text PDF (47 KB)
Message from the Editor Michael J. Droller page 185 Full Text | Full-Text PDF (43 KB)
World Urologic Oncology Federation (WUOF): History, mandate, and progress Laurence Klotz pages 186-187 Full Text | Full-Text PDF (696 KB)
Whitmore Lecture
Kidney cancer: Past, present, and future Andrew C. Novick pages 188-195 Full Text | Full-Text PDF (2248 KB)
Original Articles
Does a delay in initiating definitive therapy affect biochemical recurrence rates in men with clinically localized prostate cancer? Joseph J. Phillips, M. Craig Hall, W. Robert Lee, Peter E. Clark pages 196-200 Abstract | Full Text | Full-Text PDF (225 KB)
Magnetic resonance imaging of bone metastases in patients with nonseminomatous germ cell tumors Michael Froehner, Peter Aikele, Bettina Beuthien-Baumann, Thomas Kittner, Sven Oehlschlaeger, Manfred P. Wirth pages 201-206 Abstract | Full Text | Full-Text PDF (799 KB)
Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial Chia-Chi Lin, Chih-Hung Hsu, Tzyh-Chyuan Hour, Ann-Lii Cheng, Chao-Yuan Huang, Kuo-How Huang, Jun Chen, Yeong-Shiau Pu pages 207-213 Abstract | Full Text | Full-Text PDF (161 KB)
The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: A comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer Jesco Pfitzenmaier, William J. Ellis, Sarah Hawley, Edward W. Arfman, Jeffrey R. Klein, Paul H. Lange, Robert L. Vessella pages 214-220 Abstract | Full Text | Full-Text PDF (285 KB)
Bacillus Calmette-Guérin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway Guangjian Zhang, Fanghong Chen, Yanli Cao, William A. See pages 221-227 Abstract | Full Text | Full-Text PDF (501 KB)
The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer Mark L. Gonzalgo, Ram H. Datar, Mark P. Schoenberg, Richard J. Cote pages 228-235 Abstract | Full Text | Full-Text PDF (157 KB)
Solitary breast cancer metastasis to the bladder: An unusual occurrence Ralph M. Zagha, Karim J. Hamawy pages 236-239 Abstract | Full Text | Full-Text PDF (436 KB)
Seminar Section Introduction
Inflammatory links to bladder and prostate cancer Angelo M. De Marzo pages 240-241 Full Text | Full-Text PDF (51 KB)
Seminar Articles
Inflammation in the etiology of prostate cancer: An epidemiologic perspective Siobhan Sutcliffe, Elizabeth A. Platz pages 242-249 Abstract | Full Text | Full-Text PDF (134 KB)
Genetic variability in inflammation pathways and prostate cancer risk Jielin Sun, Aubrey Turner, Jianfeng Xu, Henrik Grönberg, William Isaacs pages 250-259 Abstract | Full Text | Full-Text PDF (150 KB)
Chronic inflammation and bladder cancer Dominique S. Michaud pages 260-268 Abstract | Full Text | Full-Text PDF (164 KB)
Letter to Editor
Reply to Forster et al Thiru Gunendran, Andrew M. Sinclair page 269 Full Text | Full-Text PDF (46 KB)
Survey Section Editorial Board page 270 Full-Text PDF (35 KB)
Urologic Oncology Survey
Long-term outcome of hematuria home screening for bladder cancer in men: Messing EM, Madeb R, Young T, Gilchrist KW, Bram L, Greenberg EB, Wegenke JD, Stephenson L, Gee J, Feng C, Department of Urology, University of Rochester, Rochester, NY H. Barton Grossman page 271 Abstract | Full Text | Full-Text PDF (56 KB)
Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response: van der Heijden AG, Moonen PM, Cornel EB, Vergunst H, de Reijke TM, van Boven E, Barten EJ, Puri R, van Kalken CK, Witjes JA, University Medical Centre Nijmegen, Nijmegen, The Netherlands H. Barton Grossman pages 271-272 Abstract | Full Text | Full-Text PDF (61 KB)
The effect of ofloxacin on bacillus calmette-guerin induced toxicity in patients with superficial bladder cancer: results of a randomized, prospective, double-blind, placebo controlled, multicenter study: Colombel M, Saint F, Chopin D, Malavaud B, Nicolas L, Rischmann P, Service d’Urologie et Chirurgie de la Transplantation, Hôpital Edouard Herriot, Universite Claude Bernard, 5, France H. Barton Grossman page 272 Abstract | Full Text | Full-Text PDF (35 KB)
Variations in reconstruction after radical cystectomy: Gore JL, Saigal CS, Hanley JM, Schonlau M, Litwin MS, Urologic Diseases in America Project, Department of Urology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA H. Barton Grossman pages 272-273 Abstract | Full Text | Full-Text PDF (42 KB)
Natural history of positive urinary cytology after radical cystectomy: Raj GV, Bochner BH, Serio AM, Vickers A, Donat SM, Herr H, Lin O, Dalbagni G, Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY H. Barton Grossman page 273 Abstract | Full Text | Full-Text PDF (35 KB)
Should we screen for bladder cancer in a high-risk population? A cost per life-year saved analysis: Lotan Y, Svatek RS, Sagalowsky AI, Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX William A. See page 274 Abstract | Full Text | Full-Text PDF (35 KB)
Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder? Schumacher MC, Scholz M, Weise ES, Fleischmann A, Thalmann GN, Studer UE, Department of Urology, Institute of Pathology, University Hospital Bern, Bern, Switzerland William A. See pages 274-275 Abstract | Full Text | Full-Text PDF (40 KB)
Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer: International Bladder Cancer Nomogram Consortium, Bochner BH, Kattan MW, Vora KC, Department of Urology, Memorial Sloan-Kettering Cancer Center, Kimmel Center for Prostate and Urologic Tumors, New York, NY William A. See page 275 Abstract | Full Text | Full-Text PDF (35 KB)
Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? Herr HW, Donat SM, Dalbagni G, Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY William A. See page 276 Abstract | Full Text | Full-Text PDF (34 KB)
Clinical model of lifetime cost of treating bladder cancer and associated complications: Avritscher EB, Cooksley CD, Grossman HB, Sabichi AL, Hamblin L, Dinney CP, Elting LS, Section of Health Services Research, Department of Biostatistics and Applied Mathematics, University of Texas M.D. Anderson Cancer Center, Houston, TX William A. See pages 276-277 Abstract | Full Text | Full-Text PDF (41 KB)
PTEN deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation: Wang S, Garcia AJ, Wu M, Lawson DA, Witte ON, Wu H, Departments of Molecular and Medical Pharmacology and Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA Paul C. Marker page 277 Abstract | Full Text | Full-Text PDF (36 KB)
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells: Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG, Department of Carcinogenesis, The University of Texas MD Anderson Cancer Center, Science Park-Research Division, Smithville, TX Paul C. Marker pages 277-278 Abstract | Full Text | Full-Text PDF (41 KB)
Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer: Berezovska OP, Glinskii AB, Yang Z, Li XM, Hoffman RM, Glinsky GV, Translational and Functional Genomics Laboratory, Ordway Cancer Center, Ordway Research Institute, Inc., Center for Medical Sciences, Albany, NY Paul C. Marker pages 278-279 Abstract | Full Text | Full-Text PDF (41 KB)
The Polycomb group protein EZH2 directly controls DNA methylation: Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden JM, Bollen M, Esteller M, Di Croce L, de Launoit Y, Fuks F, Free University of Brussels, Faculty of Medicine, Laboratory of Molecular Virology, 808 route de Lennik, 1070 Brussels, Belgium Paul C. Marker pages 279-280 Abstract | Full Text | Full-Text PDF (39 KB)
Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway: Datta MW, Hernandez AM, Schlicht MJ, Kahler AJ, DeGueme AM, Dhir R, Shah RB, Farach-Carson C, Barrett A, Datta S, Department of Pathology, Emory University, Atlanta, GA Paul C. Marker page 280 Abstract | Full Text | Full-Text PDF (33 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
